Literature DB >> 16204599

Physiological response to the six-minute walk test in pulmonary arterial hypertension.

G Deboeck1, G Niset, J-L Vachiery, J-J Moraine, R Naeije.   

Abstract

The 6-min walk test (6MWT) is commonly used to evaluate exercise capacity in patients with pulmonary arterial hypertension (PAH). However, little is known about the corresponding metabolic stress as measured by cardiopulmonary exercise testing. The present study, therefore, measured ventilatory variables and heart rate during the 6MWT and symptom-limited incremental maximal exercise testing in 20 patients with PAH. The distance walked in 6 min was 450+/-22 m (mean+/-se). During the 6MWT, ventilation, O2 consumption, CO2 production and heart rate increased during the first 3-4 min, and then remained stable. As compared with the maximum values measured during the cardiopulmonary exercise test, O2 consumption tended to be higher (14.2+/-0.6 versus 12.9+/-0.7 mL.kg-1.min-1), while maximum ventilation (46+/-3 versus 57+/-4 L.min-1), respiratory quotient (0.90+/-0.02 versus 1.15+/-0.02) and heart rate (119+/-4 versus 135+/-4 beats.min-1) remained lower. In conclusion, patients with pulmonary arterial hypertension exercise at higher aerobic capacity and lower metabolic stress during the 6MWT than during a cardiopulmonary exercise test.

Entities:  

Mesh:

Year:  2005        PMID: 16204599     DOI: 10.1183/09031936.05.00031505

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

Review 1.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

2.  Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension.

Authors:  G Valli; C D Vizza; P Onorati; R Badagliacca; R Ciuffa; R Poscia; F Brandimarte; F Fedele; P Serra; P Palange
Journal:  Eur J Appl Physiol       Date:  2007-11-03       Impact factor: 3.078

3.  Step climbing capacity in patients with pulmonary hypertension.

Authors:  Benjamin Daniel Fox; David Langleben; Andrew Hirsch; Kim Boutet; Avi Shimony
Journal:  Clin Res Cardiol       Date:  2012-08-09       Impact factor: 5.460

4.  Physical Activity and Symptoms in Pulmonary Arterial Hypertension.

Authors:  Lea Ann Matura; Haochang Shou; Jason S Fritz; K Akaya Smith; Anjali Vaidya; Diane Pinder; Christine Archer-Chicko; Danielle Dubow; Harold I Palevsky; Marilyn S Sommers; Steven M Kawut
Journal:  Chest       Date:  2016-02-15       Impact factor: 9.410

5.  Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis.

Authors:  Buse Ozcan Kahraman; Aylin Tanriverdi; Nazenin Hande Sezgin; Serap Acar; Ahmet Merih Birlik; Aydan Koken Avsar; Bahri Akdeniz; Ebru Ozpelit; Sema Savci
Journal:  Wien Klin Wochenschr       Date:  2022-09-26       Impact factor: 2.275

6.  Six Minute Walk Test to assess functional capacity in chronic liver disease patients.

Authors:  Hatem F Alameri; Faisal M Sanai; Manal Al Dukhayil; Nahla A Azzam; Khalid A Al-Swat; Ahmad S Hersi; Ayman A Abdo
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

7.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

8.  Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency.

Authors:  Gerrina Ruiter; Emmy Manders; Chris M Happé; Ingrid Schalij; Herman Groepenhoff; Luke S Howard; Martin R Wilkins; Harm J Bogaard; Nico Westerhof; Willem J van der Laarse; Frances S de Man; Anton Vonk-Noordegraaf
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

9.  Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension.

Authors:  Gaël Deboeck; Dolores Taboada; Guy Hagan; Carmen Treacy; Kathy Page; Karen Sheares; Robert Naeije; Joanna Pepke-Zaba
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.

Authors:  Fabricio Martins Valois; Luiz Eduardo Nery; Roberta Pulcheri Ramos; Eloara Vieira Machado Ferreira; Celia Camelo Silva; Jose Alberto Neder; Jaquelina Sonoe Ota-Arakaki
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.